Coherus BioSciences (CHRS)
(Delayed Data from NSDQ)
$1.90 USD
-0.22 (-10.38%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.90 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.04 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | -540.00% |
ABR | 1.60 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.01 |
Next Year | 0.68 |
EPS (TTM) | -1.59 |
P/E (F1) | 190.00 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 68.00M | 73.00M | 287.00M | 356.00M |
# of Estimates | 1 | 1 | 2 | 2 |
High Estimate | 68.00M | 73.00M | 324.00M | 432.00M |
Low Estimate | 68.00M | 73.00M | 250.00M | 280.00M |
Year ago Sales | 58.72M | 74.57M | 257.24M | 287.00M |
Year over Year Growth Est. | 15.80% | -2.11% | 11.57% | 24.04% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.04 | 0.03 | 0.01 | 0.68 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.04 | 0.03 | 0.01 | 0.68 |
Low Estimate | -0.04 | 0.03 | 0.01 | 0.68 |
Year ago EPS | -0.38 | -0.27 | -1.98 | 0.01 |
Year over Year Growth Est. | 89.47% | 111.11% | 100.51% | 6,700.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.04 | 0.03 | 0.01 | 0.68 |
7 Days Ago | -0.04 | 0.03 | 0.01 | 0.68 |
30 Days Ago | -0.04 | 0.03 | 0.01 | 0.68 |
60 Days Ago | NA | NA | -0.35 | 0.46 |
90 Days Ago | NA | NA | -0.35 | 0.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.04 | 0.03 | 0.01 | 0.68 |
Zacks Consensus Estimate | -0.04 | 0.03 | 0.01 | 0.68 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.62 | -0.27 | -0.38 | NA |
Estimate | -0.05 | -0.21 | -0.21 | -0.52 | NA |
Difference | -0.27 | -0.41 | -0.06 | 0.14 | -0.15 |
Surprise | -540.00% | -195.24% | -28.57% | 26.92% | -184.22% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more